News

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

RADNOR, Pa., Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services…

1 year ago

Mercy Executive Named Among Top Data/AI Leaders in Nation

ST. LOUIS, Sept. 27, 2024 /PRNewswire/ -- Mercy's industry-leading work in data and artificial intelligence has placed Byron Yount, PhD, chief…

1 year ago

Alpha Omega wins Best Digital Transformation Award at Unqork + AI Hackathon

VIENNA, Va., Sept. 27, 2024 /PRNewswire/ -- Alpha Omega, a leader in mission-focused technology solutions, proudly announces that we have been awarded…

1 year ago

Epic calls on Particle Health to approve release of resolution in patient privacy dispute

VERONA, Wis., Sept. 27, 2024 /PRNewswire/ -- Epic and our customers protect the privacy of many Americans' health data. At…

1 year ago

Hyivy Health Secures $2M Seed to Unlock New Model for Treating Pelvic Pain

Pelvic health startup Hyivy Health poised to offer better solutions to the 300M patients with pelvic floor dysfunction causing chronic…

1 year ago

Patients for Patient Safety US Applauds the Biden-Harris Administration for Prioritizing Patient Safety

WASHINGTON, DC / ACCESSWIRE / September 27, 2024 / On September 17th, World Patient Safety Day (WPSD), the Biden-Harris Administration…

1 year ago

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC / ACCESSWIRE / September 27,…

1 year ago

Introducing Compassion Center Austin: Pioneering Natural Wellness Solutions Through the Texas Compassionate Use Program (TCUP)

Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP).…

1 year ago

Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion

WARSAW, POLAND / ACCESSWIRE / September 27, 2024 / Humaneva Inc. has entered into a significant investment agreement with Viking…

1 year ago

MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024

Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIAMI, FL / ACCESSWIRE / September 27, 2024…

1 year ago